Literature DB >> 23215794

Transanal inside-out rectal resection for ultra-low rectal cancer.

Yung-Sung Yeh1, Ming-Jenn Chen, Hsiang-Lin Tsai, Ming-Yii Huang, Chao-Wen Chen, Yu-Ho Huang, Maw-Chang Sheen, Jaw-Yuan Wang.   

Abstract

Two major issues encountered in the surgical resection of low rectal cancers (tumor located <6 cm from anal verge) are tumor-free surgical resection margin and adequate fields of colo-anal pull-through anastomosis. The clinical consequences of ensuring gross tumor-free surgical resection margin by transanal inside-out rectal resection technique were assessed for ultra-low rectal cancer patients. From February 2009 to September 2011, ultra-low anterior resection with a new method of eversion of the rectum through the anal canal after resecting the distal rectum and colo-anal anastomosis extracorporally performed in 30 patients (age range, 41-80 years) was reviewed. All patients received preoperative neoadjuvant concurrent chemoradiotherapy (CCRT) before the surgical resection. The median operating time was 265 min (range, 220-400 min), and the median intraoperative blood loss was 325 ml (range, 80-855 ml). No in-hospital mortality was noted among these patients. R0 resection (tumor-free margin range, 0.9-2.5 cm) was confirmed in all patients by pathologic reports, except one patient with 0.5 cm tumor-free margin. The new surgical technique of transanal inside-out rectal resection and colo-anal pull-through anastomosis for selected patients with ultra-low rectal cancers seems to be a safe and alternative procedure.

Entities:  

Mesh:

Year:  2012        PMID: 23215794     DOI: 10.3109/08941939.2012.655369

Source DB:  PubMed          Journal:  J Invest Surg        ISSN: 0894-1939            Impact factor:   2.533


  2 in total

1.  Evaluation of the learning curve for conformal sphincter preservation operation in the treatment of ultralow rectal cancer.

Authors:  Hai-Bo Ding; Lin-Hui Wang; Ge Sun; Guan-Yu Yu; Xian-Hua Gao; Kuo Zheng; Hai-Feng Gong; Jin-Ke Sui; Xiao-Ming Zhu; Wei Zhang
Journal:  World J Surg Oncol       Date:  2022-03-30       Impact factor: 2.754

2.  Helical tomotherapy combined with capecitabine in the preoperative treatment of locally advanced rectal cancer.

Authors:  Ming-Yii Huang; Chin-Fan Chen; Chun-Ming Huang; Hsiang-Lin Tsai; Yung-Sung Yeh; Cheng-Jen Ma; Chan-Han Wu; Chien-Yu Lu; Chee-Yin Chai; Chih-Jen Huang; Jaw-Yuan Wang
Journal:  Biomed Res Int       Date:  2014-05-06       Impact factor: 3.411

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.